Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the AI In Cancer Diagnostics Market Size Changed, over the years?

The market size for AI in cancer diagnostics has seen a substantial rise in the past few years. Expected to rise from $0.66 billion in 2024 to $0.79 billion in 2025, it boasts a compound annual growth rate (CAGR) of 21.0%. The historical increase in this market is due in part to growing rates of cancer incidence, a surge in healthcare data, favourable regulatory scenarios, an emphasis on precision medicine, and the widening of AI applications beyond imaging.

How Much Will the AI In Cancer Diagnostics Market Be Worth in 2029?

Projected to expand rapidly over the coming years, the AI in cancer diagnostics market is anticipated to reach a value of $1.64 billion by 2029, marking a compound annual growth rate (CAGR) of 19.9%. The anticipated growth within this forecast period can be linked to the rise of explainable AI, an upsurge in global healthcare IT expenditure, harmonization with electronic health records (EHR), the embracement of personalized medicine, and the continual progression in AI algorithms. Noteworthy trends during this forecast period encompass advancements in imaging technologies, technology convergence, partnerships between the healthcare and technology sectors, the emergence of digital pathology and the increase in automation within histopathology.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13567&type=smp

Which is the Largest Company in the AI In Cancer Diagnostics Market?

Major companies operating in the AI in cancer diagnostics market report are Microsoft Corporation, IBM Corporation, Babylon Healthcare Services Ltd., Verily Life Sciences LLC, Tempus, Guardant Health, Lunit Inc., Paige AI Inc., Ada Health GmbH, Viz.ai Inc., Butterfly Network Inc., Insilico Medicine, BenevolentAI SA SA, Enlitic Inc., Ibex Medical Analytics, Kheiron Medical Technologies Limited, CureMetrix Inc., CancerIQ Inc., MultiplAI Health, Freenome Holdings Inc., SkinVision, Entopsis, Owkin, Imagen Technologies, Panakeia Technologies, EchoPixel Inc., X-Zell Inc., Cyrcadia Health, Oncora Medical, Xilis

What Are the Main Market Drivers in the AI In Cancer Diagnostics Industry?

The escalating incidence rate of cancer is predicted to boost the expansion of artificial intelligence in the cancer diagnostics market. Cancer, a collection of diseases characterized by abnormal cell growth capable of invading or spreading to other body parts, is being tackled more efficiently and accurately through AI integration. This seeks to enhance tailored treatment options for cancer patients, ultimately improving their health outcomes. For example, the US government agency, National Cancer Institute, predicted an influx of around 2 million new cancer cases in the US in May 2024, with predicted deaths exceeding 611,000. By 2040, new diagnoses of cancer globally could mount up to 29.9 million, while cancer-related deaths might peak at 15.3 million. Therefore, this mounting incidence of cancer is fuelling the progression of artificial intelligence in the cancer diagnostics market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13567&type=smp

How Is the AI In Cancer Diagnostics Market Segments Structured?

The AI in cancer diagnostics market covered in this report is segmented –

1) By Component: Software Solutions, Hardware, Services

2) By Cancer Type: Breast Cancer, Lung Cancer, Brain Tumor, Skin Cancer And Cervical Cancer, Prostate And Colorectal Cancer, Other Cancer Types

3) By Application: Screening And Diagnosis, Tumor Identification, Monitoring

4) By End User: Hospitals, Diagnostic Centers, Medical Research Institutes, Contract Research Organizations

Subsegments:

1) By Software Solutions: Machine Learning Software, Deep Learning Software, Image Analysis Software

2) By Hardware: AI-Powered Imaging Systems, Diagnostic Devices

3) By Services: AI Integration Services, Consulting And Training Services, Support And Maintenance Services

What Strategic Trends Are Transforming the AI In Cancer Diagnostics Market?

Significant growth is being witnessed by leading firms in the AI in cancer diagnostics market, thanks to the advancement of AI-enhanced digital pathology solutions used in cancer diagnosis. These solutions involve the employment of AI algorithms to identify cancer and other diagnostic traits across various tissue types, thereby facilitating precise, timely cancer diagnosis, aiding in case prioritization, and ensuring diagnostic consistency. For example, in November 2023, Dedalus & Ibex Medical Analytics, a European healthcare software company, introduced an all-encompassing AI-driven digital pathology method for cancer diagnosis throughout Europe. The solution’s goal is to boost accuracy, introduce AI-powered decision-making aids, simplify reporting, improve lab efficiency, and bolster diagnostic assurance.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/ai-in-cancer-diagnostics-global-market-report

Which Global Regions Offer the Highest Growth in the AI In Cancer Diagnostics Market?

North America was the largest region in the artificial intelligence in cancer diagnostics market in 2024. The regions covered in the ai in cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13567

This Report Delivers Insight On:

1. How big is the ai in cancer diagnostics market, and how is it changing globally?

2. Who are the major companies in the ai in cancer diagnostics market, and how are they performing?

3. What are the key opportunities and risks in the ai in cancer diagnostics market right now?

4. Which products or customer segments are growing the most in the ai in cancer diagnostics market?

5. What factors are helping or slowing down the growth of the ai in cancer diagnostics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model